Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

An updated patent review of BRD4 degraders

Expert Opinion on Therapeutic Patents(2024)10.1080/13543776.2024.2400166Source: DataRank Database

An updated patent review of BRD4 degraders is a research paper published in Expert Opinion on Therapeutic Patents (2024). On theSindex it has a DataRank of 0. It has been cited 24 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access24 citations

Download PDF

Cite:

Linked data & code

nct pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 4.46)OA: greenTopics (42)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Cun Zhang ORCID,Andrew A. Bolinger,Jia Zhou ORCID,Zonghui Ma ORCID

Live enrichment

PubMed:39219068 PMC:PMC11427152 OpenAlex:https://openalex.org/W4402141005

Crohn's & Colitis Foundation

Grant: 688953

Crohn's & Colitis Foundation

Grant: 923759

NIAID NIH HHS

Grant: R01 AI157852

NIAID NIH HHS

Grant: R21 AI176297

NIDA NIH HHS

Grant: U18 DA052546

John D. Stobo, M.D. Distinguished Chair Endowment

Edith & Robert Zinn Chair Endowment in Drug Discovery

National Institutes of Health, Crohn’s & Colitis Foundation

FWCI

4.46

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

green

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11427152/pdf/nihms-2023577.pdf

GREENhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11427152/pdf/nihms-2023577.pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11427152/pdf/nihms-2023577.pdf

publisherhttps://www.tandfonline.com/doi/pdf/10.1080/13543776.2024.2400166

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11427152/

Fields of Study

Protein Degradation and InhibitorsClick Chemistry and ApplicationsChromatin Remodeling and CancerMedicineChemistryHumansPatents as TopicTranscription FactorsCell Cycle ProteinsNeoplasmsAnimalsAntineoplastic AgentsDrug DevelopmentMolecular Targeted TherapyProteolysisDrug DiscoveryBromodomain Containing Proteins

MeSH Terms

Drug DevelopmentBromodomain Containing ProteinsAnimalsAntineoplastic AgentsHumansNeoplasmsPatents as TopicTranscription FactorsCell Cycle ProteinsDrug DiscoveryMolecular Targeted TherapyProteolysis

Keywords

Computational biologyComputer scienceChemistryBusinessBiologyInhibitorsProtein degradationEpigenetic regulationBromodomain-containing Protein 4 (Brd4)DegradersMolecular Glue (Mg)Proteolysis-targeting Chimera (Protac)Disease Therapeutics